BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2007
View Archived Issues
Snapshots of dipeptidyl peptidase IV inhibitors from the EASD annual meeting
Read More
Survival benefit seen with picoplatin in small cell lung cancer patients
Read More
PTC-299 reduces growth of breast cancer xenografts
Read More
HE-3235 inhibits growth of MNU-induced breast tumors in rats
Read More
Recent Eisai patent reports new antipruritic agents for atopic dermatitis
Read More
Recent FibroGen patent discloses novel HIF prolyl hydroxylase inhibitors
Read More
5-HT4 receptor agonists: potential antidepressant agents with a rapid onset of action
Read More
Alba Therapeutics commences phase IIb trial of oral AT-1001 for celiac disease
Read More
NCI-sponsored trials broaden clinical development of ImClone Systems' IMC-A12
Read More
Inhibitex broadens pipeline with acquisition of FermaVir
Read More
Callisto completes patient enrollment in phase II atiprimod trial
Read More
NV1FGF angiogenesis therapy enters phase III clinical evaluation
Read More
CHDI to evaluate potential of Intellect Neuroscience's Oxigon in Huntington's disease
Read More
Wyeth discontinues development of LXR regulator
Read More
Immtech's pafuramidine granted FDA orphan drug status in African sleeping sickness
Read More
Update on Teva's edratide in systemic lupus erythematosus
Read More
Antibodies with therapeutic potential enter preclinical evaluation at Xencor
Read More
Cobiprostone tested in phase II trial for prevention of NSAID-induced ulcers in arthritis patients
Read More
Patient enrollment completed in Medicure's pivotal phase III MED-CABG II trial
Read More
FDA requires further clinical study on Alcon's Retaane suspension for wet AMD
Read More
BioCryst's peramivir does not reach primary endpoint in phase II influenza trial
Read More
Novel small molecule from Enzo protects against periodontitis-associated bone loss
Read More
CHMP issues positive opinion for Onyx and Bayer's Nexavar for HCC
Read More
Cephalon submits Treanda NDA for CLL to FDA
Read More
Merck and HVTN discontinue clinical trials of HIV vaccine V-520
Read More
Sigma 1 receptor blockade mediates the antiamnesic effects of Anavex 1-41
Read More
EC approves Pfizer's CCR5 antagonist and oral entry inhibitor Celsentri
Read More
CHMP issues positive opinion for Merck Serono's Cyanokit for cyanide poisoning
Read More
European Commission approves once-daily Exelon patch for Alzheimer's disease
Read More
